Disinfectant
- 1416.286
- -10.325-0.72%
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Peking promotes the large-scale deployment of 10,000 embodied Siasun Robot&Automation, with policy support accelerating industry development.
The "Peking Embodied Asia Vets Technology Innovation and Industry Cultivation Action Plan (2025-2027)" was officially released in Peking. The "Action Plan" states that by 2027, efforts will aim to implement the large-scale deployment of ten thousand embodied Siasun Robot&Automation units and cultivate a trillion-level industrial cluster.
The volatility of Technology stocks has intensified in the short term, waiting for low-buy opportunities after risks are fully released.
Track the entire lifecycle of the main Sector.
Siasun Robot&Automation, Deepseek and other main themes are repeatedly active, pay attention to the possibility of further differentiation after the emotional climax.
Track the entire lifecycle of the main Sector.
Counter-cyclical layout of high-performance fluorinated New Materials, Zhejiang Juhua invested 4.2 billion yuan to increase its stake in Gansu Juhua | Quick Announcement
① After the completion of the high-performance fluorinated new materials project, the average annual sales revenue will be 8.211 billion yuan, with an average annual net income of 1.068 billion yuan; ② Zhejiang Juhua stated that the high-performance fluorinated new materials project is an urgent need for Zhejiang Juhua to maintain its leading position in fluorinated refrigerants and fluoropolymers; ③ In recent years, market competition in fluoropolymers has been fierce, being at the bottom of the industry cycle, and major domestic fluorochemical competitors have been approaching resource areas.
DeepSeek's popularity surged over the weekend, and related industry chain companies are expected to ride the wave.
① The AI company DeepSeek, under the Algo brand Huange, became an overnight sensation, trending across major mainstream media and social media in the USA. ② A report from CITIC SEC indicates that the smaller parameter size of the DeepSeek model compared to the GPT-4 model also means lower inference costs, and the reduction in inference costs will be a precursor to the widespread adoption of AI applications.
For the first time since上市, Shanghai Jahwa United plans to propose an impairment of goodwill exceeding 0.5 billion.
Is the extreme contrary to the opposite?
Dalian Bio-Chem increased its investment in Chipwise by 0.1 billion yuan, and many semiconductor giants have appeared on the latest shareholder list of the symbol company | Read the announcement quickly.
① This evening, Dalian Bio-Chem announced that its wholly-owned subsidiary, Xinaohua, has signed an agreement with the new actual controller, current Shareholders, and Other investors of Xinhuilianxin to plan an investment of 0.1 billion yuan, Hold 10.48% of its equity, and become the second largest Shareholder of Xinhuilianxin; ② Xinhuilianxin specializes in wafer bonding equipment, and among the company's current investors are several semiconductor giants such as Semiconductor Manufacturing International Corporation, GigaDevice Semiconductor Inc., Changxin, and others.
The expectation of alumina production boosts the market for caustic soda, and the profitability of related listed companies is expected to improve | Industry Dynamics.
① Driven by expectations of downstream Aluminum oxide expansion, on January 7, the Futures Block Orders contract SH2505 for caustic soda reached a high of 3068 yuan/ton, refreshing a nearly one-year high during the trading session; ② Tangshan Sanyou Chemical Industries stated that, supported by the growth in demand for downstream Aluminum oxide and electrolytic Aluminum, caustic soda prices are expected to be running at a high level in 2025.
The State Council meeting deployed to deepen the regulatory reform of Pharmaceutical and medical instruments, and Institutions indicated that there are significant structural opportunities in the Pharmaceutical Industry.
According to media reports, the recent State Council executive meeting deployed measures to deepen the regulation reform of pharmaceuticals and medical instruments, promoting the high-quality development of the pharmaceutical industry. Orient stated that looking back at 2024, the high base from the past has been digested, and the intra-hospital rigid demand is being released normally. Meanwhile, the Industry Chain of Innovative Drugs and the export of instruments continue to yield results, and the overall growth logic is clearly visible.
Major asset restructuring changes, jinfa labi intends to reduce the acquisition of the target equity to 51% | Speed reading announcement
① Jinfa Labi has terminated the major asset restructuring, changing to the acquisition of 51% equity in Zhuhai Hanfei and Zhongshan Hanfei, which does not constitute a major asset restructuring. ② Jinfa Labi has incurred net income losses for two consecutive years, with revenue of 0.139 billion yuan in the first three quarters, down 7.63% year-on-year, and a net income attributable to shareholders of -9.9525 million yuan.
Refrigerant leader zhejiang juhua: Some products in Q4 have stabilized and stopped falling, opportunities outweigh challenges next year | Directly hit the earnings conference
①It is expected that refrigerant prices will rebound comprehensively in Q4, while non-refrigerants will stabilize; ②Look optimistically at next year's performance prospects, highlighting the coexistence of opportunities and challenges; ③Next year, the upward trend of refrigerants is strong, and the competitive landscape has improved somewhat; ④Non-refrigerants are still in surplus, but the risks of a large decline over the past two years have been released.
Investors are paying attention to the progress of FT606. Shandong Lukang Pharmaceutical did not directly respond to the production time | Live coverage of the earnings conference
① The company's new synthetic biotechnology material product FT606 has attracted much attention. ② The pharmaceutical industry was in the traditional off-season in the third quarter, leading to a decline in the company's Q3 performance. ③ In the earnings conference, a questioner claiming to be an investor expressed dissatisfaction with the lack of interaction.
Below expectations? Refrigerant prices are steadily rising, zhejiang juhua's Q3 net profit declined compared to the previous quarter|Interpretations
1. The company's Q3 net profit declined compared to the previous quarter, and investor comments were below expectations; 2. It is becoming increasingly difficult to meet the full-year performance expectations set by the brokerage; 3. The structural contradictions of the product are prominent, with some products continuously dragging down performance; 4. The off-season for refrigerants in Q3 also had an impact, but demand in Q4 has not shown a clear increase.
Share buyback shareholding loans quickly landed! ICBC, BOC, ABC, CMB, CITIC and other first batch of multiple banks announced progress. Some banks have already shown cooperation intentions with nearly a hundred listed companies.
1. As of now, Bank of China has reached cooperation intentions with nearly a hundred listed companies, with 32 listed companies explicitly promised loans, covering multiple industries such as integrated circuits, transportation, high-end manufacturing, and business services; 2. The banks stated that they will strictly adhere to the risk compliance bottom line, rigorously prevent crediting funds that do not meet the conditions of stock increase stake & buyback and refinancing policies from illegally flowing into the stock market.
Higher pork prices have enabled listed pig enterprises to enter a "profit-making mode", with Beijing Dabeinong Technology Group's Q3 achieving the peak of annual profits.|interpretations
①Supported by the rise in pork prices, Beijing Dabeinong Technology Group expects to achieve a net income of 2.8 billion-3.2 billion yuan in Q3, a year-on-year growth of 308.4%-338.17%; ②Some industry insiders believe that the breeding sector may continue to maintain reasonable profitability in Q4, and Beijing Dabeinong Technology Group may benefit from the dual-track performance support of the hog and seed sectors.
Disinfectant leader enters the semiconductor equipment field, Dalian Bio-Chem plans to acquire Chip Wise for 0.7 billion yuan | Speed read announcement
①Dalian Bio-Chem plans to acquire the semiconductor automation equipment company Chip Brain Connect for 0.7 billion yuan, while also injecting no more than 0.1 billion yuan into the spin-off company "Chip Brain Connect New"； ②Currently, Chip Brain Connect has a total order backlog of nearly 0.3 billion yuan, with an expected year-on-year revenue growth of 177%； ③Chip Brain Connect's original shareholders have committed that the company's net income for 2024-2026 will not be less than 0.1 billion yuan, 0.15 billion yuan, and 2.5 billion yuan.
The overall weakness of fluorine chemical industry is revealed despite the soaring refrigerant prices. Zhejiang Juhua's Q2 net profit is lower than the peak in the same period of 2022 | Interpretations
① In Q2, zhejiang juhua had a net profit attributable to shareholders of 0.524 billion yuan, which was lower than the same period of 2022; ② The net profit attributable to shareholders in H1 increased by 70.31% year on year, and there is great pressure for profit growth in H2; ③ The refrigerant is outstanding, while other fluorine chemical products are dragging down the performance; ④ The company's diversified layout does not have an advantage in the current stage of the industry.
Beijing Dabeinong Technology Group turned its losses into profits in Q2 of the pig cycle, and the dual tracks of breeding and pigs may become a support point for H2 performance.|Interpretation of financial statements
① With the upward impact of the pig cycle, Beijing Dabeinong Technology Group significantly reduced its losses in the first half of the year and turned losses into profits in the second quarter; ② Hindered by the overall downturn in the fodder industry, the company's fodder sales volume decreased by 8.92% year-on-year during the reporting period; ③ The pig market in the second half of the year is expected to remain at a high level, and the company's seed profits will also be reflected in the second half of the year. The dual-track development strategy will provide support for H2 performance.
The suspected pollution of Erkang Pharmaceuticals' Cambodian factory was evicted due to a local request and an announcement will be made later
Serious pollution